Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Rich Plasma for Musculoskeletal Conditions
NCT07231471Recruiting
- Sponsor
- University of Utah
- Start
- Dec 2025
- Primary completion
- Jan 2035
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Open-label, single-arm trial of platelet-rich plasma in osteoarthritis (OA), tendinopathy, epicondylitis and 1 more, sponsored by University of Utah. Primary endpoint: Visual Analog Scale for Pain at 6 months. Started Dec 2025; status: recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
osteoarthritis (OA)tendinopathyepicondylitisplantar fasciitis
Beyond the preview
Go deeper on NCT07231471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07231471.